As expected, the expression levels of hepatic Uba5, Ufc1, Ufl1, and Ufm1 are significantly reduced in patients with obesity, MASLD, and MASH by analyzing the public data sets (Figure 1A–C). This evidence concerns the gene UFM1 and obesity disorder.